Minister for Health and Active Ageing, Jo Etienne Abela, has announced the launch of a new insulin pump service, which will ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...

Tandem Diabetes Care, Inc.’s TNDM share price has surged by 6.26%, which has investors questioning if this is right time to ...

Q1 2025 Earnings Call Transcript April 30, 2025 Tandem Diabetes Care, Inc. misses on earnings expectations. Reported EPS is $ ...

Tandem Diabetes (TNDM) stock surged 20% after a record ex-US sales performance boosted its Q1 2025 revenue by 22% YoY. Read ...

Tandem Diabetes Care reported that worldwide sales increased to $234.4 million for its first quarter 2025, an increase of 22% compared to the same quarter in 2024.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $34.0, a high ...

Tandem Diabetes Care Inc (TNDM) reports robust growth and strategic advancements, while navigating competitive pressures and ...

Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.

Despite the earnings miss, Tandem reaffirmed its full-year 2025 guidance, projecting revenue between $997 million and $1.007 billion, in line with the consensus estimate of $998.7 million. The company ...

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed on first-quarter results that beat the ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its ...